Gamida Cell Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016
Revenue	1.78	0	0	0	0	0	0	0
Cost of Revenue	1.45	0	0	0	0	0	0	0
Gross Profit	0.33	0	0	0	0	0	0	0
Selling, General & Admin	44.58	32.3	36.99	22.05	16.78	11.6	4.47	4.61
Research & Development	24.31	42.69	50.18	38.87	31.46	22.05	15.02	19.1
Other Operating Expenses	4.48	0	0	0	0	0	0	0
Operating Expenses	73.37	74.99	87.17	60.93	48.25	33.64	19.49	23.71
Operating Income	-73.04	-74.99	-87.17	-60.93	-48.25	-33.64	-19.49	-23.71
Interest Expense / Income	0	0	2.63	0.65	3.33	20.26	0.72	0.16
Other Expense / Income	-10.04	4.38	-	-	-17.15	-1.04	-1.2	-1.19
Pretax Income	-63	-79.38	-89.79	-61.57	-34.42	-52.86	-19.01	-22.67
Income Tax	0	0	0	0	-0.07	0.07	0	0
Net Income	-63	-79.38	-89.79	-61.57	-34.35	-52.93	-19.01	-22.67
Shares Outstanding (Basic)	110	64	59	44	25	5	1	1
Shares Outstanding (Diluted)	110	64	59	44	-	5	1	1
Shares Change	72.42%	7.73%	35.50%	75.39%	396.11%	628.40%	-	-
EPS (Basic)	-0.57	-1.24	-1.52	-1.41	-1.17	-10.53	-27.56	-32.86
EPS (Diluted)	-0.57	-1.24	-1.52	-1.41	-1.69	-10.53	-27.56	-32.86
Free Cash Flow	-80.17	-76.78	-96.81	-62.02	-40.99	-28.07	-16.95	-12.87
Free Cash Flow Per Share	-0.73	-1.20	-1.63	-1.42	-1.64	-5.59	-24.57	-18.66
Gross Margin	18.50%	-	-	-	-	-	-	-
Operating Margin	-4094.06%	-	-	-	-	-	-	-
Profit Margin	-3531.17%	-	-	-	-	-	-	-
Free Cash Flow Margin	-4493.72%	-	-	-	-	-	-	-
EBITDA	-60.97	-78.94	-86.74	-60.57	-28.95	-32.33	-18.13	-22.39
EBITDA Margin	-3417.71%	-	-	-	-	-	-	-
Depreciation & Amortization	2.02	0.44	0.43	0.36	2.14	0.27	0.16	0.12
EBIT	-63	-79.38	-87.17	-60.93	-31.1	-32.6	-18.29	-22.52
EBIT Margin	-3531.17%	-	-	-	-	-	-	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).